Trans Fatty Acids In Infant Formulas Should Be Limited, U.S. Tells Codex
This article was originally published in The Tan Sheet
A U.S. delegation urges Codex Alimentarius to curb the amount of trans fatty acids allowed in infant formula because of safety concerns in a draft position paper on Codex' proposed standards for infant formula.
You may also be interested in...
A substantiation model for health-related claims for food - which would allow different levels of supporting evidence based on the type of claim - is inappropriate, the U.S. delegation to the Codex Committee on Food Labeling says in a draft position paper presented for public comment May 1.
Food marketers would be required to disclose the trans fatty acids content of products in the "Nutrition Facts" panel under an FDA proposed rule expected to be published in the Nov. 17 Federal Register. The levels of trans fat also would be considered when attempting to meet the requirements for claims regarding "low saturated fat" and "reduced saturated fat," as well as "lean," "extra lean" and cholesterol claims. Products containing more than 4 g saturated and trans fat combined per serving additionally would be prohibited from making health claims, such as the approved claim for calcium and osteoporosis. The public comment period on the proposal will run for 90 days
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC